Abstract | PURPOSE: To compare the outcome of our facility with another about the shortened schedule (60 Gy in 10 fractions to 54 Gy in 9 fractions) of high-dose-rate interstitial brachytherapy (HDR ISBT) for mobile tongue cancer. MATERIAL AND METHODS: Eighteen patients were treated with HDR ISBT as a monotherapy in dose reduction schedule with some unique technique to determine the border of tumor accuracy (lugol's staining and metal marker), and to minimize adverse effect (lead-lined silicon block) at our facility. RESULTS: The 2-year local and regional control rates and cause-specific survival rate were 82%, 80%, and 83% and moderate to severe late complications occurred in five patients (28%), which were almost the same treatment results achieved by another facility. CONCLUSIONS: We recommend 54 Gy in 9 fractions over 7 days as a feasible treatment to reduce patient discomfort in mobile tongue cancer patients.
|
Authors | Hironori Akiyama, Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, Tadayuki Kotsuma, Koji Masui, Yasuo Yoshioka, Takumi Arika, Kimishige Shimizutani, Eiichi Tanaka |
Journal | Journal of contemporary brachytherapy
(J Contemp Brachytherapy)
Vol. 6
Issue 1
Pg. 10-4
(Mar 2014)
ISSN: 1689-832X [Print] Poland |
PMID | 24790616
(Publication Type: Journal Article)
|